Facebook
Twitter
LinkedIn
Forward2024 Leveraging Fluency Direct Technology: Best Practices for Optimizing User Profiles for Improving Efficiency within the EMR
In this interactive, hands-on course, clinicians will explore the functionality of M-Modal's Fluency Direct editing tools and how to effectively use to them help gain time back in their day spent making corrections.
This course will be offered monthly between January - June 2024. The list below will be updated as new dates become available.
| Date (all dates listed are Thursdays) | Time |
| January 18 | 12:00 pm - 1:30 pm |
| February 22 | 12:00 pm - 1:30 pm |
| March 21 | 12:00 pm - 1:30 pm |
| April 25 | 12:00 pm - 1:30 pm |
| May 23 | 12:00 pm - 1:30 pm |
| June 27 | 12:00 pm - 1:30 pm |
Please note, registration for this course is limited to 8 learners per session. A waitlist will be made available once a session is full.
Intended Audience
This activity is designed for health care providers at UW Health who utilize Fluency Direct software and wish to further knowledge of the system's capabilities to improve productivity and accuracy.
Learning Objectives
By participating in this activity learners will be able to:
- Demonstrate proficiency with dictation technology including calibrating devices and correcting text.
- Identify the importance of specific editing tools to enhance productivity and aid with documentation.
- Examine facility-approved best practices for reducing documentation errors.
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
| Name | Role(s) | Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
| Pegan (Kiern) Koehlinger Physician Services Program Analyst UW Health | Course Director Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Scott Bennett Physician Services Program Analyst UW Health | Course Director Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Ann Brown Physician Services Program Manager UW Health | Planning Committee Member Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Jason Dambach, MD Medical Informatics & Director - Provider Experience UW Health | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose | No |
| Jeremy Peacock, MD Medical Informatics - Dept. of Psychiatry UW Health | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose | No |
| Kristen Panther, NP Program Manager - APP Education UW Health | Planning Committee Member | No relevant financial relationships with ineligible companies to disclose | No |
| Julie Bies Physician Services Program Analyst UW Health | Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Michele Nickels Physician Services Program Analyst UW Health | Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Doug Drake Physician Services Program Analyst UW Health | Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
| Jennifer Erickson Physician Services Program Analyst UW Health | Faculty/Speaker | No relevant financial relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live in-person activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live in-person activity for a maximum of 1.5 ANCC contact hours. Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .015 CEUs or 1.5 hours. | |
Please note, registration for this course is limited to 8 learners per session.
Learners will be screened to make sure they meet eligibility requirements for the course. Learners who are not eligible for the course will be automatically unenrolled.